InvestorsHub Logo

mjt

Followers 2
Posts 210
Boards Moderated 0
Alias Born 08/22/2016

mjt

Re: mjt post# 5019

Friday, 01/12/2018 2:07:15 PM

Friday, January 12, 2018 2:07:15 PM

Post# of 7900
Corrected post info:

Again, this is what Senhance has that DaVinci doesn't:

-open architecture
-interfaces with current hospitals devices
-haptic feedback
-eye sensing camera control
-comfortable ergonomics
-reusable instruments (that ISRG charges big $ for)
-easy instrument exchange
-significantly less expensive device
-mimics current laparoscopy making it easy to learn
-3mm instruments already being utilized in EU, making virtually scarless
surgery!

FDA approval only 3 mos ago, and there is a 4-6 quarter sales cycle. There are some marketing limitations before an FDA approval has been submitted and once submitted no purchase orders can be requested or accepted. Cost cannot be discussed.

You cannot compare a company's sales that has had a monopoly for 17 years of sales to a company's sales, that has only had an FDA approval for 3 months!

TRXC is on the right track.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ASXC News